DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rallied 1.49% to $723.41 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.11% to 49,760.56 and the S&P 500 Index falling 0.16% to 7,400.96.
Regeneron Pharmaceuticals Inc. closed 11.90% short of its 52-week high of $821.11, which the company achieved on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Amgen Inc. $(AMGN)$ rose 2.03% to $336.29, Moderna Inc. (MRNA) rose 0.74% to $53.27, and Gilead Sciences Inc. (GILD) rose 1.06% to $134.94.
Trading volume (802,732) eclipsed its 50-day average volume of 681,930.
Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 12, 2026 16:43 ET (20:43 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments